188 related articles for article (PubMed ID: 35769782)
1. BUB1 Is Identified as a Potential Therapeutic Target for Pancreatic Cancer Treatment.
Li M; Duan X; Xiao Y; Yuan M; Zhao Z; Cui X; Wu D; Shi J
Front Public Health; 2022; 10():900853. PubMed ID: 35769782
[TBL] [Abstract][Full Text] [Related]
2. High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma.
Piao J; Zhu L; Sun J; Li N; Dong B; Yang Y; Chen L
Gene; 2019 Jun; 701():15-22. PubMed ID: 30898709
[TBL] [Abstract][Full Text] [Related]
3. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561
[TBL] [Abstract][Full Text] [Related]
5. A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766T.
Hempen PM; Kurpad H; Calhoun ES; Abraham S; Kern SE
Hum Mutat; 2003 Apr; 21(4):445. PubMed ID: 12655561
[TBL] [Abstract][Full Text] [Related]
6. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].
Li X; He J; Yu M; Zhang W; Sun J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212
[TBL] [Abstract][Full Text] [Related]
7. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of BUB1 expression and gene regulation network in lung adenocarcinoma.
Wang L; Yang X; An N; Liu J
Transl Cancer Res; 2020 Aug; 9(8):4820-4833. PubMed ID: 35117845
[TBL] [Abstract][Full Text] [Related]
9. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
10. Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation.
Ricke RM; van Deursen JM
Cell Cycle; 2011 Nov; 10(21):3645-51. PubMed ID: 22033440
[TBL] [Abstract][Full Text] [Related]
11. BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma.
Qi W; Bai Y; Wang Y; Liu L; Zhang Y; Yu Y; Chen H
APMIS; 2022 Jul; 130(7):371-382. PubMed ID: 35255180
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.
Li YY; Mukaida N
World J Gastroenterol; 2014 Jul; 20(28):9392-404. PubMed ID: 25071334
[TBL] [Abstract][Full Text] [Related]
13. Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint.
Huggett MT; Tudzarova S; Proctor I; Loddo M; Keane MG; Stoeber K; Williams GH; Pereira SP
Oncotarget; 2016 Apr; 7(14):18495-507. PubMed ID: 26921250
[TBL] [Abstract][Full Text] [Related]
14. The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.
Rojanala S; Han H; Muñoz RM; Browne W; Nagle R; Von Hoff DD; Bearss DJ
Mol Cancer Ther; 2004 Apr; 3(4):451-7. PubMed ID: 15078988
[TBL] [Abstract][Full Text] [Related]
15. BUB1 promotes proliferation of liver cancer cells by activating SMAD2 phosphorylation.
Zhu LJ; Pan Y; Chen XY; Hou PF
Oncol Lett; 2020 May; 19(5):3506-3512. PubMed ID: 32269624
[TBL] [Abstract][Full Text] [Related]
16. Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation.
Ricke RM; Jeganathan KB; van Deursen JM
J Cell Biol; 2011 Jun; 193(6):1049-64. PubMed ID: 21646403
[TBL] [Abstract][Full Text] [Related]
17. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
[TBL] [Abstract][Full Text] [Related]
18. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
[TBL] [Abstract][Full Text] [Related]
19. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.
Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z
Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921
[TBL] [Abstract][Full Text] [Related]
20. Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression.
Ricke RM; Jeganathan KB; Malureanu L; Harrison AM; van Deursen JM
J Cell Biol; 2012 Dec; 199(6):931-49. PubMed ID: 23209306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
